Researchers randomly assigned 697 adult volunteers to receive their second dose of either the mRNA vaccine from Pfizer/BioNTech or the viral-vector vaccine from AstraZeneca/Oxford, along with one of three influenza vaccines for the 2020-2021 season or a ...
from Google Alert - health https://ift.tt/3kGa9SR
via IFTTT
0 comments:
Post a Comment